Validation of the Residual Cancer Burden Index as a prognostic tool in women with locally advanced breast cancer treated with neoadjuvant chemotherapy.

Juliana Pierobon Gomes da CunhaRodrigo GoncalvesFernando SilvaFernando Nalesso AguiarBruna Salani MotaBruna Bello ChequimJosé Maria SoaresEdmund C BaracatJosé Roberto Filassi

Published in: Journal of clinical pathology (2021)

We demonstrated a positive and significant relationship between the RCB index and the risk of relapse and death.

Keyphrases

neoadjuvant chemotherapy
locally advanced
rectal cancer
squamous cell carcinoma
papillary thyroid
sentinel lymph node
lymph node
phase ii study
radiation therapy
squamous cell
lymph node metastasis
free survival
risk factors
newly diagnosed